A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects
Clinical trial NCT07079618 · COMPLETED
Trial details
- NCT number
- NCT07079618
- Sponsor
- Beijing Sungen Biomedical Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2025-07-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.